4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001680329-26-000002
Director sold 734 shares at $76.00 ($55,784)
- Director acquired 734 shares (option exercise)
- Director acquired 4,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Reeve Emma · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form 10b5-1 | +4,000 | 10,666 | D | ||
| 2026-01-05 | Exercise or conversion : show line 2 in the form 10b5-1 | +734 | $46.54 | $34,160 | 11,400 | D |
| 2026-01-05 | Sale : show line 3 in the form 10b5-1 | −734 | $76.00 | $55,784 | 10,666 | D |
| Open-market sales · 734 sh · avg $76.00 · $55,784 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | +3,475 | 3,475 | D |
| 2026-01-05 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −734 | 0 | D |
Loading xslF345X05/form4-01062026_050117.xml…